PFM Health Sciences as of June 30, 2021
Portfolio Holdings for PFM Health Sciences
PFM Health Sciences holds 80 positions in its portfolio as reported in the June 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Alexion Pharmaceuticals | 5.2 | $166M | 901k | 183.71 | |
Horizon Therapeutics Pub L SHS | 4.7 | $149M | 1.6M | 93.64 | |
Outset Med (OM) | 4.6 | $148M | 3.0M | 49.98 | |
Eli Lilly & Co. (LLY) | 3.8 | $121M | 526k | 229.52 | |
Neurocrine Biosciences (NBIX) | 3.4 | $109M | 1.1M | 97.32 | |
Abbvie (ABBV) | 3.3 | $104M | 927k | 112.64 | |
Arcus Biosciences Incorporated (RCUS) | 3.0 | $96M | 3.5M | 27.46 | |
Myriad Genetics (MYGN) | 3.0 | $95M | 3.1M | 30.58 | |
Centene Corporation Call Option (CNC) | 2.9 | $93M | 1.3M | 72.93 | |
Iqvia Holdings (IQV) | 2.7 | $87M | 358k | 242.32 | |
ACADIA Pharmaceuticals Call Option (ACAD) | 2.6 | $83M | 3.4M | 24.39 | |
Hca Holdings (HCA) | 2.5 | $81M | 391k | 206.74 | |
Seagen | 2.4 | $76M | 483k | 157.88 | |
Avantor (AVTR) | 2.3 | $74M | 2.1M | 35.51 | |
Universal Hlth Svcs CL B (UHS) | 2.2 | $71M | 487k | 146.43 | |
Nevro (NVRO) | 2.2 | $69M | 419k | 165.79 | |
McKesson Corporation (MCK) | 2.1 | $68M | 356k | 191.24 | |
Humana (HUM) | 2.0 | $63M | 142k | 442.72 | |
UnitedHealth (UNH) | 1.8 | $58M | 145k | 400.44 | |
Edwards Lifesciences (EW) | 1.7 | $53M | 513k | 103.57 | |
ICU Medical, Incorporated (ICUI) | 1.6 | $53M | 256k | 205.80 | |
Aerie Pharmaceuticals Note 1.500%10/0 (Principal) | 1.5 | $48M | 48M | 1.00 | |
Biomarin Pharmaceutical Note 0.599% 8/0 (Principal) | 1.5 | $48M | 46M | 1.04 | |
Danaher Corporation (DHR) | 1.5 | $47M | 176k | 268.36 | |
Guardant Health (GH) | 1.5 | $47M | 374k | 124.19 | |
Mirati Therapeutics | 1.5 | $46M | 287k | 161.53 | |
Gilead Sciences (GILD) | 1.4 | $46M | 667k | 68.86 | |
Biogen Idec (BIIB) | 1.4 | $46M | 132k | 346.27 | |
Tenet Healthcare Corp Com New (THC) | 1.4 | $45M | 667k | 66.99 | |
Myovant Sciences | 1.4 | $44M | 1.9M | 22.77 | |
Intellia Therapeutics Call Option (NTLA) | 1.3 | $43M | 263k | 161.91 | |
Waters Corporation (WAT) | 1.3 | $41M | 118k | 345.61 | |
Cytokinetics Com New Call Option (CYTK) | 1.2 | $39M | 2.0M | 19.79 | |
Baxter International (BAX) | 1.2 | $37M | 459k | 80.50 | |
Syndax Pharmaceuticals (SNDX) | 1.2 | $37M | 2.1M | 17.17 | |
Penumbra (PEN) | 1.1 | $37M | 134k | 274.06 | |
Aerie Pharmaceuticals | 1.1 | $35M | 2.2M | 16.01 | |
Heron Therapeutics (HRTX) | 1.1 | $34M | 2.2M | 15.52 | |
Moderna Put Option (MRNA) | 1.0 | $33M | 141k | 234.98 | |
Novavax Com New (NVAX) | 1.0 | $32M | 149k | 212.31 | |
Icon SHS (ICLR) | 0.9 | $30M | 144k | 206.71 | |
Dynavax Technologies Corp Com New (DVAX) | 0.9 | $30M | 3.0M | 9.85 | |
Butterfly Network Com Cl A (BFLY) | 0.8 | $27M | 1.8M | 14.48 | |
Cano Health Com Cl A | 0.8 | $25M | 2.1M | 12.10 | |
Arena Pharmaceuticals Com New | 0.7 | $24M | 346k | 68.20 | |
Jounce Therapeutics | 0.7 | $22M | 3.3M | 6.80 | |
Karuna Therapeutics Ord | 0.7 | $22M | 193k | 113.99 | |
Ionis Pharmaceuticals Note 0.125%12/1 (Principal) | 0.7 | $21M | 23M | 0.93 | |
Molina Healthcare (MOH) | 0.6 | $18M | 70k | 253.05 | |
Zai Lab Adr (ZLAB) | 0.6 | $18M | 99k | 176.99 | |
Thermo Fisher Scientific (TMO) | 0.6 | $18M | 35k | 504.46 | |
Laboratory Corp Amer Hldgs Com New (LH) | 0.6 | $18M | 64k | 275.85 | |
Constellation Pharmceticls I | 0.5 | $16M | 470k | 33.80 | |
Allogene Therapeutics (ALLO) | 0.5 | $16M | 607k | 26.08 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.5 | $16M | 3.6M | 4.26 | |
Astrazeneca Sponsored Adr (AZN) | 0.4 | $13M | 209k | 59.90 | |
Lifestance Health Group (LFST) | 0.4 | $12M | 444k | 27.86 | |
BioCryst Pharmaceuticals (BCRX) | 0.4 | $11M | 709k | 15.81 | |
Galapagos Nv Spon Adr (GLPGF) | 0.3 | $10M | 178k | 58.48 | |
Fs Development Corp Ii Com Cl A | 0.3 | $10M | 1.0M | 10.00 | |
Pmv Pharmaceuticals (PMVP) | 0.3 | $9.8M | 288k | 34.16 | |
Shattuck Labs (STTK) | 0.3 | $9.5M | 327k | 28.99 | |
Innovage Hldg Corp (INNV) | 0.3 | $9.2M | 430k | 21.31 | |
Praxis Precision Medicines I | 0.3 | $8.3M | 455k | 18.28 | |
Novavax Note 3.750% 2/0 (Principal) | 0.2 | $7.6M | 4.3M | 1.79 | |
Vectivbio Hldg Ord Shs | 0.2 | $7.1M | 611k | 11.66 | |
Werewolf Therapeutics (HOWL) | 0.2 | $7.0M | 400k | 17.44 | |
Athira Pharma (ATHA) | 0.2 | $6.9M | 678k | 10.24 | |
Kinnate Biopharma (KNTE) | 0.2 | $6.2M | 264k | 23.28 | |
D Fluidigm Corp Del (LAB) | 0.2 | $6.0M | 981k | 6.16 | |
Pulmonx Corp (LUNG) | 0.2 | $6.0M | 137k | 44.12 | |
Silverback Therapeutics (SPRY) | 0.2 | $5.8M | 188k | 30.89 | |
1life Healthcare | 0.2 | $5.7M | 172k | 33.06 | |
Bcls Acquisition Corp Com Cl A | 0.2 | $4.9M | 464k | 10.53 | |
Jiya Acquisition Corp Com Cl A | 0.1 | $4.6M | 464k | 9.94 | |
Certara Ord (CERT) | 0.1 | $4.1M | 143k | 28.33 | |
Oak Street Health | 0.1 | $3.9M | 67k | 58.57 | |
Nevro Corp Note 2.750% 4/0 (Principal) | 0.1 | $3.5M | 2.0M | 1.74 | |
Doximity Cl A (DOCS) | 0.1 | $1.7M | 30k | 58.20 | |
Allena Pharmaceuticals | 0.0 | $370k | 284k | 1.30 |